In Vitro Services
Our in vitro services group can support late stage discovery and development phase projects using cell based assays and biochemical based methods. We are able to grow and maintain commercial cell lines in dedicated facilities to study aspects such as biopotency, toxicity, metabolism etc. Our current end point assays use ELISA or spectrophotometric technology. We have developed and validated commercial kits as well as more bespoke assays based on client requirements e.g. enzyme activity or absolute measurement of specific biochemicals (e.g. hormones). We have also carried out investigative studies and supported non-clinical and clinical studies.
- Biochemical assays e.g. enzyme assays, biomarkers, etc
- Cell based assays
- Metabolism based assays e.g. plasma protein binding, metabolic stability (microsomes, hepatocytes) etc.
- Radioactive assays
- GLP / GCP compliant assays
MHRA SymposiumThe 2018 MHRA Symposium will be attended by John McRoberts, Head of QA.
MHRA SymposiumDates: 20th NovemberLocation: London, UK
AAPS: PharmSci360This years' PharmSci360 conference will be attended by Masha Kononov, Senior Director Emerging Biotech US.
AAPS: PharmSci360Dates: 4th - 7th NovemberLocation: Washington DC, US
Bio-Europe 2018Bio-Europe autumn conference will be attended by Nathalie Huther, Business Development Manager Europe.
Bio-Europe 2018Dates: 5th - 7th NovemberLocation: Copenhagen, Denmark